The Cytokine Network in Colorectal Cancer: Implications for New Treatment Strategies

Overview

Journal Cells

Publisher MDPI

Specialties Biochemistry
Biophysics
Cell Biology
Molecular Biology

Date 2023 Jan 8

PMID 36611932

Authors

Heidi Braumuller

Bernhard Mauerer

Johanna Andris

Christopher Berlin

Thomas Wieder

Rebecca Kesselring

Affiliations

Soon will be listed here.

Abstract

Colorectal cancer (CRC) is one of the most frequent tumor entities worldwide with only limited therapeutic options. CRC is not only a genetic disease with several mutations in specific oncogenes and/or tumor suppressor genes such as APC, KRAS, PIC3CA, BRAF, SMAD4 or TP53 but also a multifactorial disease including environmental factors. Cancer cells communicate with their environment mostly via soluble factors such as cytokines, chemokines or growth factors to generate a favorable tumor microenvironment (TME). The TME, a heterogeneous population of differentiated and progenitor cells, plays a critical role in regulating tumor development, growth, invasion, metastasis and therapy resistance. In this context, cytokines from cancer cells and cells of the TME influence each other, eliciting an inflammatory milieu that can either enhance or suppress tumor growth and metastasis. Additionally, several lines of evidence exist that the composition of the microbiota regulates inflammatory processes, controlled by cytokine secretion, that play a role in carcinogenesis and tumor progression. In this review, we discuss the cytokine networks between cancer cells and the TME and microbiome in colorectal cancer and the related treatment strategies, with the goal to discuss cytokine-mediated strategies that could overcome the common therapeutic resistance of CRC tumors.

Citing Articles

Protective Effect of Ganjang, a Traditional Fermented Soy Sauce, on Colitis-Associated Colorectal Cancer in Mice.

Lim H, Park I, Kim M, Seo J, Ha G, Yang H Foods. 2025; 14(4).

PMID: 40002076 PMC: 11854912. DOI: 10.3390/foods14040632.

Colorectal Cancer: Current and Future Therapeutic Approaches and Related Technologies Addressing Multidrug Strategies Against Multiple Level Resistance Mechanisms.

Puzzo M, De Santo M, Morelli C, Leggio A, Catalano S, Pasqua L Int J Mol Sci. 2025; 26(3).

PMID: 39941081 PMC: 11818749. DOI: 10.3390/ijms26031313.

Enhanced Antitumor Efficacy and Reduced Toxicity in Colorectal Cancer Using a Novel Multifunctional Rg3- Targeting Nanosystem Encapsulated with Oxaliplatin and Calcium Peroxide.

Xie Y, Zhu M, Bao H, Chen K, Wang S, Dai J Int J Nanomedicine. 2025; 20:1021-1046.

PMID: 39877588 PMC: 11774109. DOI: 10.2147/IJN.S502076.

Multiomics analysis reveals the involvement of NET1 in tumour immune regulation and malignant progression.

Pang J, Huang X, Gao Y, Guan X, Xiong L, Li L Sci Rep. 2025; 15(1):56.

PMID: 39747410 PMC: 11695589. DOI: 10.1038/s41598-024-83714-8.

Unique structural configuration of EV-DNA primes Kupffer cell-mediated antitumor immunity to prevent metastatic progression.

Wortzel I, Seo Y, Akano I, Shaashua L, Tobias G, Hebert J Nat Cancer. 2024; 5(12):1815-1833.

PMID: 39627554 DOI: 10.1038/s43018-024-00862-6.

References

Bule P, Aguiar S, Aires-da-Silva F, Dias J . Chemokine-Directed Tumor Microenvironment Modulation in Cancer Immunotherapy. Int J Mol Sci. 2021; 22(18). PMC: 8464715. DOI: 10.3390/ijms22189804. View

McLaughlin M, Patin E, Pedersen M, Wilkins A, Dillon M, Melcher A . Inflammatory microenvironment remodelling by tumour cells after radiotherapy. Nat Rev Cancer. 2020; 20(4):203-217. DOI: 10.1038/s41568-020-0246-1. View

Perez L, Kempski J, McGee H, Pelzcar P, Agalioti T, Giannou A . TGF-β signaling in Th17 cells promotes IL-22 production and colitis-associated colon cancer. Nat Commun. 2020; 11(1):2608. PMC: 7248087. DOI: 10.1038/s41467-020-16363-w. View

Bergmann H, Roth S, Pechloff K, Kiss E, Kuhn S, Heikenwalder M . Card9-dependent IL-1β regulates IL-22 production from group 3 innate lymphoid cells and promotes colitis-associated cancer. Eur J Immunol. 2017; 47(8):1342-1353. PMC: 5600091. DOI: 10.1002/eji.201646765. View

Drewes J, Chen J, Markham N, Knippel R, Domingue J, Tam A . Human Colon Cancer-Derived Clostridioides difficile Strains Drive Colonic Tumorigenesis in Mice. Cancer Discov. 2022; 12(8):1873-1885. PMC: 9357196. DOI: 10.1158/2159-8290.CD-21-1273. View

Wilson M, Jiang Y, Villalta P, Stornetta A, Boudreau P, Carra A . The human gut bacterial genotoxin colibactin alkylates DNA. Science. 2019; 363(6428). PMC: 6407708. DOI: 10.1126/science.aar7785. View

Nastasi C, Candela M, Bonefeld C, Geisler C, Hansen M, Krejsgaard T . The effect of short-chain fatty acids on human monocyte-derived dendritic cells. Sci Rep. 2015; 5:16148. PMC: 4635422. DOI: 10.1038/srep16148. View

Senchukova M, Tomchuk O, Shurygina E . in gastric cancer: Features of infection and their correlations with long-term results of treatment. World J Gastroenterol. 2021; 27(37):6290-6305. PMC: 8515796. DOI: 10.3748/wjg.v27.i37.6290. View

Lynch H, de la Chapelle A . Hereditary colorectal cancer. N Engl J Med. 2003; 348(10):919-32. DOI: 10.1056/NEJMra012242. View

10.

Lin Y, He Z, Ye J, Liu Z, She X, Gao X . Progress in Understanding the IL-6/STAT3 Pathway in Colorectal Cancer. Onco Targets Ther. 2020; 13:13023-13032. PMC: 7762435. DOI: 10.2147/OTT.S278013. View

11.

Percario R, Panaccio P, di Mola F, Grottola T, Di Sebastiano P . The Complex Network between Inflammation and Colorectal Cancer: A Systematic Review of the Literature. Cancers (Basel). 2021; 13(24). PMC: 8699209. DOI: 10.3390/cancers13246237. View

12.

Boleij A, Hechenbleikner E, Goodwin A, Badani R, Stein E, Lazarev M . The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients. Clin Infect Dis. 2014; 60(2):208-15. PMC: 4351371. DOI: 10.1093/cid/ciu787. View

13.

Hall D, Benndorf R . Aspirin sensitivity of PIK3CA-mutated Colorectal Cancer: potential mechanisms revisited. Cell Mol Life Sci. 2022; 79(7):393. PMC: 9250486. DOI: 10.1007/s00018-022-04430-y. View

14.

Zhong X, Chen B, Yang Z . The Role of Tumor-Associated Macrophages in Colorectal Carcinoma Progression. Cell Physiol Biochem. 2018; 45(1):356-365. DOI: 10.1159/000486816. View

15.

Rubinstein M, Wang X, Liu W, Hao Y, Cai G, Han Y . Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. Cell Host Microbe. 2013; 14(2):195-206. PMC: 3770529. DOI: 10.1016/j.chom.2013.07.012. View

16.

Reimers M, Engels C, Putter H, Morreau H, Liefers G, van de Velde C . Prognostic value of HLA class I, HLA-E, HLA-G and Tregs in rectal cancer: a retrospective cohort study. BMC Cancer. 2014; 14:486. PMC: 4094545. DOI: 10.1186/1471-2407-14-486. View

17.

Dufait I, Schwarze J, Liechtenstein T, Leonard W, Jiang H, Escors D . Ex vivo generation of myeloid-derived suppressor cells that model the tumor immunosuppressive environment in colorectal cancer. Oncotarget. 2015; 6(14):12369-82. PMC: 4494944. DOI: 10.18632/oncotarget.3682. View

18.

Balkwill F, Mantovani A . Cancer-related inflammation: common themes and therapeutic opportunities. Semin Cancer Biol. 2012; 22(1):33-40. DOI: 10.1016/j.semcancer.2011.12.005. View

19.

Ciszewski C, Discepolo V, Pacis A, Doerr N, Tastet O, Mayassi T . Identification of a γc Receptor Antagonist That Prevents Reprogramming of Human Tissue-resident Cytotoxic T Cells by IL15 and IL21. Gastroenterology. 2019; 158(3):625-637.e13. PMC: 7861144. DOI: 10.1053/j.gastro.2019.10.006. View

20.

Wang Y, Fletcher R, Yu J, Zhang L . Immunogenic effects of chemotherapy-induced tumor cell death. Genes Dis. 2018; 5(3):194-203. PMC: 6176216. DOI: 10.1016/j.gendis.2018.05.003. View